BK
61
-4
GRMN
52
-3
ESS
45
-6
AMZN
59
-2
PPL
44
-3
CL
47
-3
ITW
45
-3
NTRS
44
-3
EQR
36
-3
VTR
43
-3
WHR
57
-2
WEC
39
-2
PDCO
75
-2
F
40
-2
ORCL
51
-4
MTB
38
-3
CHD
34
-5
PPG
57
-4
GS
55
-3
CINF
27
-11
BK
61
-4
GRMN
52
-3
ESS
45
-6
AMZN
59
-2
PPL
44
-3
CL
47
-3
ITW
45
-3
NTRS
44
-3
EQR
36
-3
VTR
43
-3
WHR
57
-2
WEC
39
-2
PDCO
75
-2
F
40
-2
ORCL
51
-4
MTB
38
-3
CHD
34
-5
PPG
57
-4
GS
55
-3
CINF
27
-11
Financhill
Back

AstraZeneca PLC 10K Form

Buy
51

AZN
AstraZeneca PLC

Last Price:
$66.26
Seasonality Move:
1.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZN News And Ratings

See the #1 stock for the next 7 days that we like better than AZN

AZN Financial Statistics

Sales & Book Value

Annual Sales: $45.8B
Cash Flow: $2B
Price / Cash Flow: 30.64
Annual Sales: $13.13
Price / Book: 5.05

Profitability

EPS (TTM): 2.08500
Net Income (TTM): $6.5B
Gross Margin: $37.5B
Return on Equity: 16.72%
Return on Assets: 6.38%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 26 years for AZN is 81.95%.
  • The Selling, General & Administrative Expenses for AZN have been equal to 39.78% of Gross Profit Margin.
  • The Research & Development expenses have been 23.87% of Revenue.
  • The Interest Expense is 26.68% of Operating Income.
  • The Net Earning history of AZN is 13.00% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 19 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AZN
CUSIP: 046353
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.74
Current Ratio: 0.93
Quick Ratio: 0.71

Price-to-Earnings

Trailing P/E Ratio: 34.78
Forward P/E Ratio: 13.87

AZN Technical Analysis vs Fundamental Analysis

Buy
51
AstraZeneca PLC (AZN) is a Buy

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Buy
    The current AstraZeneca PLC [AZN] share price is $66.26. The Score for AZN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.